Insulin aspart

Results: 104



#Item
61PREFERRED STEP THERAPY POLICY Insulin (Rapid-Acting) Preferred Step Therapy Program To Initiate a Coverage Review, Call[removed]DRUGS AFFECTED: Apidra® (insulin glulisine [rDNA origin] injection – Sanofi Aventi

PREFERRED STEP THERAPY POLICY Insulin (Rapid-Acting) Preferred Step Therapy Program To Initiate a Coverage Review, Call[removed]DRUGS AFFECTED: Apidra® (insulin glulisine [rDNA origin] injection – Sanofi Aventi

Add to Reading List

Source URL: statehealthplan.state.nc.us

Language: English - Date: 2014-05-05 10:56:54
62Correct Quantities for NB Drug Plans Claim Submissions The tables below list correct quantities for various categories of medications and for a number of specific medications. If you are unsure of the correct unit of mea

Correct Quantities for NB Drug Plans Claim Submissions The tables below list correct quantities for various categories of medications and for a number of specific medications. If you are unsure of the correct unit of mea

Add to Reading List

Source URL: www.gnb.ca

Language: English - Date: 2014-06-24 09:33:12
63PREFERRED STEP THERAPY POLICY Insulin (Short- and Intermediate-Acting) Preferred Step Therapy Program To Initiate a Coverage Review, Call[removed]DRUGS AFFECTED: Humulin® R (Regular insulin human injection, USP [

PREFERRED STEP THERAPY POLICY Insulin (Short- and Intermediate-Acting) Preferred Step Therapy Program To Initiate a Coverage Review, Call[removed]DRUGS AFFECTED: Humulin® R (Regular insulin human injection, USP [

Add to Reading List

Source URL: statehealthplan.state.nc.us

Language: English - Date: 2014-05-05 10:56:55
64■ Medical Safety Information Pharmaceuticals and Medical Devices Agency http://www.pmda.go.jp/english/service/medical_info.html No. 37 April, 2013

■ Medical Safety Information Pharmaceuticals and Medical Devices Agency http://www.pmda.go.jp/english/service/medical_info.html No. 37 April, 2013

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2014-02-19 00:54:13
65Kansas Medical Assistance Program  P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed]

Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed]

Add to Reading List

Source URL: www.kdheks.gov

Language: English - Date: 2013-07-31 16:02:31
66C O M M O N LY U S E D A N T I - H Y P E R G LYC E M I C A G E N T S The following charts include commonly used medications for diabetes. For information on dosing and other considerations, please refer to pharmaceutical

C O M M O N LY U S E D A N T I - H Y P E R G LYC E M I C A G E N T S The following charts include commonly used medications for diabetes. For information on dosing and other considerations, please refer to pharmaceutical

Add to Reading List

Source URL: www.mass.gov

Language: English - Date: 2013-08-30 20:21:00
67These highlights do not include all the information needed to use NovoLog safely and effectively. See full prescribing information for NovoLog.NovoLog® (insulin aspart [rDNA origin] injection) solution for subcutaneous

These highlights do not include all the information needed to use NovoLog safely and effectively. See full prescribing information for NovoLog.NovoLog® (insulin aspart [rDNA origin] injection) solution for subcutaneous

Add to Reading List

Source URL: www.fda.gov

Language: English
68This consult is in response to CBER’s August 27, 2002, e-mail requesting assistance on providing data on the use of the product Neumega (oprelvelin)

This consult is in response to CBER’s August 27, 2002, e-mail requesting assistance on providing data on the use of the product Neumega (oprelvelin)

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2006-11-13 08:05:34
69Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology

Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology

Add to Reading List

Source URL: www.fda.gov

Language: English
70CLINICAL REVIEW   Application Type Submission Number Submission Code Letter Date

CLINICAL REVIEW Application Type Submission Number Submission Code Letter Date

Add to Reading List

Source URL: www.fda.gov

Language: English